KV Pharmaceutical Co. has lost its bid for sanctions against pharmaceutical firms Celgene Corp. and Novartis Pharma AG for failing to conduct an infringement analysis before suing KV to stop it from marketing a generic version of Ritalin LA, which treats attention deficit disorder.
The details can be read here.
No comments:
Post a Comment